| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
RESEARCH COMMUNICATION |
B by manganese-containing superoxide dismutase in human breast cancer cells
a Gene Regulation Section, Laboratory of Biochemical Physiology, National Cancer Institute, Frederick, Maryland 21702–1201; USA
b Radiation Research Laboratory, The University of Iowa, Iowa City, Iowa 52242, USA
One of the primary antioxidant enzymes, manganese-containing superoxide dismutase (MnSOD), has shown the ability to reverse malignant phenotypes in a variety of human tumor cells that are low or absent in MnSOD expression. We have observed that overexpression of human MnSOD in human breast cancer MCF-7 cells inhibits tumor growth both in vitro and in vivo. The signaling pathway underlying the MnSOD induced tumor suppression is unknown. We demonstrate here that transcriptional and DNA binding ability of AP-1 and NF-B, but not SP-1, were inhibited (by 50%) in the MCF-7 cell line overexpressing MnSOD. When transiently expressing, MnSOD inhibited AP-1 but increased NF-B transactivation, which can be abolished by sodium pyruvate, a hydrogen peroxide scavenger. To analyze the target genes responsible for MnSOD-induced tumor suppression, genes related to tumor growth and responsive to AP-1 or NF-B were analyzed. AP-1 responsive collagenase I, stromelysin I, and NF-B responsive IL-1 and IL-6 were down-regulated in the MnSOD stable transfectants compared to the control cell lines. Since TPA induces differentiation in human breast cancer cells and up-regulates MnSOD gene in HeLa cells, MnSOD expression and AP-1 and NF-B activity were measured under TPA treatment. The results showed that TPA induced endogenous MnSOD expression and inhibited both AP-1 and NF-B. Together, these results suggest that tumor suppression by overexpressing MnSOD is related to a modulation of AP-1 and NF-B, which causes a down-regulation of genes responsible for tumor malignant phenotype.—Li, J.-J., Oberley, L. W., Fan, M., Colburn. N. H. Inhibition of AP-1 and NF-B by manganese-containing superoxide dismutase in human breast cancer cells. FASEB J. 12, 1713–1723 (1998)
Key Words: tumor suppressor gene • redox • transcription factor • MCF-7 cells • TPA
This article has been cited by other articles:
|
|
 |
|
  X. Zhou, J. D. Ferraris, Q. Cai, A. Agarwal, and M. B. Burg Increased reactive oxygen species contribute to high NaCl-induced activation of the osmoregulatory transcription factor TonEBP/OREBP Am J Physiol Renal Physiol, August 1, 2005; 289(2): F377 - F385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Hodge, W. Xiao, B. Peng, J. C. Cherry, D. J. Munroe, and W. L. Farrar Enforced Expression of Superoxide Dismutase 2/Manganese Superoxide Dismutase Disrupts Autocrine Interleukin-6 Stimulation in Human Multiple Myeloma Cells and Enhances Dexamethasone-Induced Apoptosis Cancer Res., July 15, 2005; 65(14): 6255 - 6263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Matsumoto, J.-i. Namekawa, M. Muta, T. Nakamura, H. Bando, K. Tohyama, M. Toi, and K. Umezawa Targeting of Nuclear Factor {kappa}B Pathways by Dehydroxymethylepoxyquinomicin, a Novel Inhibitor of Breast Carcinomas: Antitumor and Antiangiogenic Potential In vivo Clin. Cancer Res., February 1, 2005; 11(3): 1287 - 1293. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yang and F. L. Meyskens Jr. Alterations in Activating Protein 1 Composition Correlate with Phenotypic Differentiation Changes Induced by Resveratrol in Human Melanoma Mol. Pharmacol., January 1, 2005; 67(1): 298 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Mobley and R. W. Brueggemeier Estrogen receptor-mediated regulation of oxidative stress and DNA damage in breast cancer Carcinogenesis, January 1, 2004; 25(1): 3 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. del Carmen Cordoba-Pedregosa, F. Cordoba, J. M. Villalba, and J. A. Gonzalez-Reyes Zonal Changes in Ascorbate and Hydrogen Peroxide Contents, Peroxidase, and Ascorbate-Related Enzyme Activities in Onion Roots Plant Physiology, February 1, 2003; 131(2): 697 - 706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Azevedo-Martins, S. Lortz, S. Lenzen, R. Curi, D. L. Eizirik, and M. Tiedge Improvement of the Mitochondrial Antioxidant Defense Status Prevents Cytokine-Induced Nuclear Factor-{kappa}B Activation in Insulin-Producing Cells Diabetes, January 1, 2003; 52(1): 93 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Oberley Oxidative Damage and Cancer Am. J. Pathol., February 1, 2002; 160(2): 403 - 408. [Full Text] [PDF]
|
|
|
|
|
|
C. Huang, J. Li, M. Costa, Z. Zhang, S. S. Leonard, V. Castranova, V. Vallyathan, G. Ju, and X. Shi Hydrogen Peroxide Mediates Activation of Nuclear Factor of Activated T Cells (NFAT) by Nickel Subsulfide Cancer Res., November 1, 2001; 61(22): 8051 - 8057. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Valentine Mesalamine induces manganese superoxide dismutase in rat intestinal epithelial cell lines and in vivo Am J Physiol Gastrointest Liver Physiol, October 1, 2001; 281(4): G1044 - G1050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Miranda, L. Janssen, C. B. Bosman, W. van Duijn, M. M. Oostendorp-van de Ruit, F. J. G. M. Kubben, G. Griffioen, C. B. H. W. Lamers, J. Han, J. M. van Krieken, et al. Superoxide Dismutases in Gastric and Esophageal Cancer and the Prognostic Impact in Gastric Cancer Clin. Cancer Res., August 1, 2000; 6(8): 3183 - 3192. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. I. Bello, C. Gomez-Diaz, F. Navarro, F. J. Alcain, and J. M. Villalba Expression of NAD(P)H:Quinone Oxidoreductase 1 in HeLa Cells. ROLE OF HYDROGEN PEROXIDE AND GROWTH PHASE J. Biol. Chem., November 21, 2001; 276(48): 44379 - 44384. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
